Inloggen
E-mail
Wachtwoord
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. BelgiŽ
  4. Euronext Bruxelles
  5. Argenx SE
  6. Nieuws
  7. Andere talen
    ARGX   NL0010832176

ARGENX SE

(ARGX)
Real-time koersen. Real Time Euronext Bruxelles - 04/08 17:38:41
264.5 EUR   +1.54%
30/07ARGENX : Halfjaarlijkse Financiële verslaggeving
PU
29/07Argen-x zet sterke resultaten neer
AM
19/07KBC Securities zet Argen-x op de kooplijst
AM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op ARGENX SE
04/08ARGENX : argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference
04/08ARGENX : to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference
03/08DGAP-ADHOC : Evotec SE: Positive Phase-IIb-Daten für P2X3-Antagonist in Patiente..
03/08DGAP-ADHOC : Evotec SE: Positive Phase IIb data for investigational P2X3 antagon..
02/08DGAP-ADHOC : Evotec SE gibt die vertrauliche Einreichung des Entwurfs einer Regi..
02/08DGAP-ADHOC : Evotec SE Announces Confidential Submission of Draft Registration S..
30/07European ADRs Drop Nearly 0.5% as Miners, Drillers Lag
29/07ARGENX : Swings to H1 Earnings as Revenue Jumps From Last Year
29/07ARGENX : argenx Reports Half Year 2021 Financial Results and Provides Second Qua..
29/07ARGENX : To Increase Spending In FY21 Amid Immunology Shift
29/07ARGENX : Reports Half Year 2021 Financial Results and Provides Second Quarter Bu..
29/07Argenx Se Reports Earnings Results for the Half Year Ended June 30, 2021
23/07BB BIOTECH : utile netto 1* sem a 349 mln chf (422 mln chf 1* sem 20)
23/07DGAP-NEWS : Il settore delle biotecnologie -2-
23/07DGAP-NEWS : Il settore delle biotecnologie archivia un secondo trimestre all'ins..
23/07DGAP-NEWS : Biotechbranche mit solidem 2. Quartal -2-
23/07DGAP-NEWS : Biotechbranche mit solidem 2. Quartal - BB Biotech erhöht Allokation..
23/07PRESS RELEASE : Solid second quarter for the -2-
22/07ANALYST RECOMMENDATIONS : Barclays, Chevron, Flutter, Netflix, Unilever...
22/07ARGENX : argenx to Report Half Year 2021 Financial Results and Second Quarter Bu..
22/07AVIS D'ANALYSTES DU JOUR : TotalEnergies, STMicroelectronics, Novartis, Shop Apo..
22/07argenx to Report Half Year 2021 Financial Results and Second Quarter Business..
22/07ARGENX : to Report Half Year 2021 Financial Results and Second Quarter Business ..
20/07European ADRs Up 0.5% Tuesday
20/07ANALYST RECOMMENDATIONS : Deliveroo, IBM, Intercontinental Hotels, LivaNova, Via..
20/07El coronavirus vuelve a infectar los índices bursátiles
20/07BEURS VAN PARIJS : Le coronavirus contamine à nouveau les indices
20/07AVIS D'ANALYSTES DU JOUR : Richemont, Deliveroo, ArgenX, Ericsson, Zeal, ASM Int..
19/07European ADRs Down 2.3% as Stock Markets Slump Monday
19/07AVIS D'ANALYSTES DU JOUR : Roche, Credit Suisse, Scor, ArgenX, Siemens Gamesa, P..
19/07BEURS VAN PARIJS : Le plan ne se déroule pas tout à fait comme prévu
14/07ARGENX : argenx to Host Virtual R&D Day on July 20, 2021
14/07ARGENX : to Host Virtual R&D Day on July 20, 2021
09/07European ADRs Move Sharply Higher in Friday Trading
01/07PRESS RELEASE : Evotec creates long-term growth opportunities by initiating 'Cam..
18/06PUMP / DUMP #16† : Les Tops & Flops de la semaine
17/06ARGENX : Late-Stage Study Backs Potential of Autoimmune Disease Drug Against Mya..
17/06ARGENX : Myasthenia Gravis Therapy Improves Strength, Life Quality In Trial
17/06argenx announces publication of Phase 3 ADAPT trial results of efgartigimod f..
17/06Argenx's drug effective against muscle-weakening disease myasthenia gravis
17/06Argenx Announces Publication of Phase 3 ADAPT Trial Results of Efgartigimod f..
15/06PRESS RELEASE : Evotec SE virtual Annual General Meeting 2021 approves all propo..
15/06DGAP-NEWS : Virtuelle Hauptversammlung 2021 der Evotec SE stimmt allen Beschluss..
15/06Evotec startet Initiative zur Vorbereitung auf künftige Pandemien
15/06PRESS RELEASE : Evotec launches 'PRROTECT', a pre-competitive initiative to be b..
15/06DGAP-NEWS : Evotec startet mit 'PRROTECT' eine vorwettbewerbliche Initiative zur..
09/06European ADRs Slightly Higher Wednesday With Biotechs Leading While Miners Dr..
07/06ARGENX : to regain global rights to cusatuzumab (Form 6-K)
07/06European ADRs Nudge Lower in Monday Trading
07/06SECTOR UPDATE : Health Care Stocks Gain Premarket Monday
07/06ARGENX : to Reclaim Rights to Cusatuzumab After Janssen Ends Collaboration on Le..
07/06Johnson & Johnson Ends Cusatuzumab License Deal With Argenx
07/06ARGENX SE : le cusatuzumab déçoit
07/06PRESS RELEASE : Innovative Molecules raises EUR20 million Series A equity financ..
07/06ARGENX : Reclaims Global Rights For Acute Myeloid Leukemia Treatment
07/06argenx to regain global rights to cusatuzumab
07/06Argenx to Regain Global Rights to Cusatuzumab
01/06ARGENX : Appoints Karl Gubitz as Chief Financial Officer (Form 6-K)
01/06ARGENX : Taps Karl Gubitz for Finance Chief
01/06ARGENX : Names Pfizer Executive as CFO
01/06argenx Appoints Karl Gubitz as Chief Financial Officer
01/06Argenx SE Announces Executive Changes
01/06ARGENX : to Present at Upcoming Investor Conferences
14/05GLOBAL MARKETS LIVE : Airbnb, Coinbase, Walt Disney,...
14/05ARGENX : Posts Narrower Q1 Loss, Revenue Rises; Reaffirms 2021 Outlook
14/05BEURS VAN PARIJS : Des bourses à géographie variable
14/05EN DIRECT DES MARCHES : Veolia / Suez, Walt Disney, Airbnb, Eurofins, Coinbase, ..
14/05argenx Reports First Quarter 2021 Financial Results and Provides Business Upd..
11/05argenx announces results of Annual General Meeting of Shareholders
11/05Argenx SE Announces Board Changes
11/05WERNER LANTHALER : Partnerschaften und Medikamentenentwicklung treiben Evotec we..
11/05ARGENX : announces results of Annual General Meeting of Shareholders (Form 6-K)
10/05GALAPAGOS NV : les ambitions de croissance externe n'enthousiasment pas le march..
07/05EQS-ADHOC : HBM Healthcare Investments erzielt im Geschäftsjahr 2020/2021 einen ..
07/05argenx to Report First Quarter 2021 Financial Results and Business Update on ..
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op ARGENX SE
10/08/21